The immunological implications of paradoxical reactions in rheumatoid arthritis and psoriasis treatment: A case report
Fatimah Mohammad Budair 1 2 * , Haya A. AlHemli 1 , Adel A. Zeidan 1 , Abdullah Alshehri 1 2 , Jumana Alratroot 1 3 , Manal Hasan 1 4
More Detail
1 College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, SAUDI ARABIA2 Department of Dermatology, King Fahad Hospital of the University, Al Khobar, SAUDI ARABIA3 Department of Pathology, King Fahad Hospital of the University, Al Khobar, SAUDI ARABIA4 Division of Rheumatology, Department of Internal Medicine, King Fahad Hospital of the University, Al Khobar, SAUDI ARABIA* Corresponding Author

Abstract

Psoriasis and rheumatoid arthritis (RA) are common chronic diseases with distinctive histological and molecular features. However, there are similarities in their immunological pathogenesis, leading to the use of some similar systemic biological treatment. In 5% of patients using biological therapy such as the anti-tumor necrosis factor alpha (anti-TNF-α), a paradoxical reaction (i.e., the exacerbation or development of one disease while treating the other) may develop. We report a case of a 27-year-old female diagnosed with seropositive RA who developed paradoxical psoriasis (PP) after the use of Adalimumab, an anti-TNF-α, and paradoxical eczema due to the use of Ixekizumab, an anti-interleukin-17A, for the treatment of PP. This case demonstrates the occurrence of two different types of paradoxical skin reactions in a single patient. This case also highlights the importance of the selection and cessation of biological treatment in similar cases, as well as the factors that might predict the development of paradoxical reactions to promote the safe usage of biological therapy.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Case Report

ELECTRON J GEN MED, Volume 21, Issue 6, December 2024, Article No: em610

https://doi.org/10.29333/ejgm/15521

Publication date: 01 Nov 2024

Online publication date: 24 Oct 2024

Article Views: 337

Article Downloads: 253

Open Access References How to cite this article